Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis

Abstract

Description

Bu çalışma, 25-28, Ekim 2017 tarihlerinde Paris[Fransa]’ de düzenlenen 7. Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Kongresi‘nde bildiri olarak sunulmuştur.

Keywords

Neurosciences & neurology

Citation

Boz, C. vd. (2017). ''Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis''. Multiple Sclerosis Journal, 23(Supplement 3), 327-328.

Collections